ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr | ₹-1,108 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALKEM LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1,738 Cr |
| Mar2024 | ₹-1,515 Cr |
| Mar2023 | ₹-1,303 Cr |
| Mar2022 | ₹-1,309 Cr |
| Mar2021 | ₹-1,108 Cr |
How is Deferred Tax Assets / Liabilities of ALKEM LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,738 Cr | Negative | |
| Mar2024 | ₹-1,515 Cr | Negative | |
| Mar2023 | ₹-1,303 Cr | Negative | |
| Mar2022 | ₹-1,309 Cr | Negative | |
| Mar2021 | ₹-1,108 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹66,950.3 Cr | -0.3% | -1.8% | 2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.3% |
-1.8% |
2.9% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses